New Therapy Offers Hope to Spinal Muscular Atrophy Patients

Topic: Therapy
Author: University of Sheffield
Published: 2010/06/09
Contents: Summary - Introduction - Main Item - Related Topics

Synopsis: Children who suffer from Spinal Muscular Atrophy set to benefit from new breakthrough in therapy development.

Introduction

Children who suffer from the devastating disease Spinal Muscular Atrophy are set to benefit from a new breakthrough in therapy developments by researchers at the University of Sheffield.

Main Item

The research, which was published yesterday (9 June 2010) in Science Translational Medicine , has shown that a novel gene transfer system has the potential to provide an effective therapeutic treatment for SMA patients.

SMA is a devastating motor neuron disease which affects children. It is caused by an abnormal survival motor neuron (SMN) gene, which leads to a reduction of SMN protein levels. The disease is currently incurable, and patients often require prolonged medical care as no effective treatments to alleviate the condition, currently exist.

The research team at Sheffield, led by Professor Mimoun Azzouz, tested whether a novel gene replacement therapy through a single injection was the most efficient way to treat the disease in a group of mice. They found that the injection, which expressed the SMN gene, successfully restored the SMN protein to normal levels and alleviated symptoms in the SMA model.

The new technique has the potential to develop a simple injection, without any requirement for risky and costly surgical interventions, and has achieved the highest therapeutic effects reported in the field to date. This has significant implications for the future treatment of SMA.

Professor Mimoun Azzouz, from the University's Department of Neuroscience, said: "I am delighted by the outcome of several years of efforts to tackle this devastating disease. These results bring us one step closer to a successful gene therapy treatment for patients with SMA."

Explore Related Topics

1 - - Neuroplasticity in cognitive control networks linked to problem-solving skills and depression recovery, revealing brain adaptations that influence mental health outcomes.

2 - - GnRH injection therapy was found to improve cognitive function in patients with Down syndrome.

3 - - Researchers find robotic pets can be helpful in therapy, without some of the disadvantages and unpredictability of real animals.

4 - - Research and literature on the therapeutic benefits of light therapy to living tissues and organisms.

5 - - Balloon Buddies game is designed to level the playing field by allowing healthy participants to support the less abled player.

Complete List of Related Information

Page Information, Citing and Disclaimer

Disabled World is a comprehensive online resource that provides information and news related to disabilities, assistive technologies, and accessibility issues. Founded in 2004 our website covers a wide range of topics, including disability rights, healthcare, education, employment, and independent living, with the goal of supporting the disability community and their families.

Cite This Page (APA): University of Sheffield. (2010, June 9). New Therapy Offers Hope to Spinal Muscular Atrophy Patients. Disabled World. Retrieved October 6, 2024 from www.disabled-world.com/medical/rehabilitation/therapy/sma-therapy.php

Permalink: <a href="https://www.disabled-world.com/medical/rehabilitation/therapy/sma-therapy.php">New Therapy Offers Hope to Spinal Muscular Atrophy Patients</a>: Children who suffer from Spinal Muscular Atrophy set to benefit from new breakthrough in therapy development.

Disabled World provides general information only. Materials presented are never meant to substitute for qualified medical care. Any 3rd party offering or advertising does not constitute an endorsement.